The Detection and Analytical Confirmation of Synthetic Fentanyl Analogues in Human Urine & Serum using an UltivoLC/TQ

Application Note Clinical Research The detection and analytical confirmation of synthetic fentanyl analogues in human urine and serum using an Agilent Ultivo LC/TQ Author Abstract Peter JW Stone Agilent Technologies, Inc. Santa Clara, CA This research study develops a sensitive,…

New Synthetics and New Innovations: Click tofentanyl edit divider title style Synthetic analogues and the new Agilent Ultivo Tandem Mass Spectrometer Click to edit divider subtitle style Julie Cichelli, Ph.D. Agilent Technologies, Wilmington, DE. 1 Introduction • Opioid crisis is…

“Incredibly Powerful, Remarkably Efficient Quantitation” Patrick M. Jeanville, Ph.D. LC/TQ Product Manager Ruben Garnica, Ph.D. MS Solutions Product Manager Yanan Yang, Ph.D. Application Scientist Jennifer Hitchcock, Ph.D. Application Scientist 1 6/4/18 ASMS 2018 Monday Morning Breakfast Session Ultivo: Innovation with…

Application Note Clinical Research A Comprehensive Approach to Targeted and Untargeted Screening Methodology for Emerging Synthetic Fentanyl Analogues High Resolution Accurate Mass Spectrometry Authors Dr. Julie Cichelli, Carrie J. Adler, and Dr. Jim Lau Agilent Technologies, Inc. Abstract In recent…